title: Tramadol-associated pericarditis.
abstract: Tramadol, marketed as Ultram in the United States, is as a non-scheduled narcotic analgesic based on its low abuse liability. It is indicated for the treatment of moderately severe pain; however, multiple adverse effects have been reported with its use including seizures, anaphylaxis, angioedema, bronchospasm, and serotonin syndrome. An association between tramadol and pericarditis has not been previously reported. We describe the case of an 88 year-old male who developed acute pericarditis 2 days following tramadol initiation. The temporal relationship between drug initiation and pericarditis as well as the resolution of symptoms upon drug discontinuation suggested a potential association. Although pericarditis has not been described with tramadol administration, clinicians should be aware of a possible association.
authors.forename: M J
authors.initials: MJ
authors.lastname: Krantz
authors.forename: J A
authors.initials: JA
authors.lastname: Garcia
authors.forename: P S
authors.initials: PS
authors.lastname: Mehler
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000701:Analgesics, Opioid / Q000009:adverse effects*; D006801:Humans; D008297:Male; D010493:Pericarditis / Q000139:chemically induced* / Q000175:diagnosis; D014147:Tramadol / Q000009:adverse effects*
chemical_list: D000701:Analgesics, Opioid; D014147:Tramadol